I'm in a dilemma. Isn't it even worth selling shares in Baxano at this point? Someone mentioned about a possible reverse-merge with a private biotech company. How would that benefit the common shareholders? It's disappointing to see the current state of Baxano compared to a year ago at this time. Extremely frustrating.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.